Jiansheng Zhu

Jiansheng Zhu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2021 in Expert Review of Vaccines
Verified
Journal Article
Closed access
MZMeixian ZHANG
Meixian ZHANG
XLXiao-Qing Lin
Xiao-Qing Lin
YCYan Chen
Yan Chen
TTTao-Hsin Tung
Tao-Hsin Tung
JZJiansheng Zhu
Jiansheng Zhu
Vaccine hesitancy seriously hinders herd immunity. We explored the determinants of parental hesitancy to vaccinate children against Coronavirus Disease 2019 (COVID-19) in China. A population-based self-administered online questionnaire evaluating parental hesitancy in vaccinating their children against COVID-19 was conducted in Taizhou, China. Of the 2463 parents who received the invitation, 1788 (72.6%) responded to the survey. Of the repondents, 52.5% were hesitant. Mothers exhibited a greater proportion of vaccine hesitancy than fathers did (57.5% vs. 41.7%, P < 0.001). Multiple logistic regression analysis indicated that parents with children under 18 years of age (OR = 0.94, 95%CI: 0.90–0.99), lower knowledge scores about COVID-19 vaccination (Q1: OR = 1.92, 95%CI: 1.37–2.69; Q2: OR = 1.51, 95%CI: 1.10–2.08), lower awareness of the permission of vaccinating children (OR = 1.74, 95%CI: 1.36–2.23) and hesitancy to inoculate themselves (OR = 8.18, 95%CI: 6.48–10.33) were associated with parental hesitancy to inoculate their children. Results also revealed the disparity between fathers and mothers regarding associated factors. This study found that a substantial proportion of parents reported being hesitant to vaccinate children against COVID-19, implying the necessity of comprehensive assessment and health education programs for vaccination systems in China.

1 April 2019 in EBioMedicine
Verified
Journal Article
Open access
KWKuifeng Wang
Kuifeng Wang
SFShanhua Fang
Shanhua Fang
QLQian Liu
Qian Liu
JGJing Gao
Jing Gao
XWXiaoning Wang
Xiaoning Wang
HZHu Zhou
Hu Zhou
Hepatic stellate cell (HSC) activation induced by transforming growth factor β1 (TGF-β1) plays a pivotal role in fibrogenesis, while the complex downstream mediators of TGF-β1 in such process are largely unknown. We performed pharmacoproteomic profiling of the mice liver tissues from control, carbon tetrachloride (CCl4)-induced fibrosis and NPLC0393 administrated groups. The target gene MAT2A was overexpressed or knocked down in vivo by tail vein injection of AAV vectors. We examined NF-κB transcriptional activity on MAT2A promoter via luciferase assay. Intracellular SAM contents were analyzed by LC-MS method. We found that methionine adenosyltransferase 2A (MAT2A) is significantly upregulated in the CCl4-induced fibrosis mice, and application of NPLC0393, a known small molecule inhibitor of TGF-β1 signaling pathway, inhibits the upregulation of MAT2A. Mechanistically, TGF-β1 induces phosphorylation of p65, i.e., activation of NF-κB, thereby promoting mRNA transcription and protein expression of MAT2A and reduces S-adenosylmethionine (SAM) concentration in HSCs. Consistently, in vivo and in vitro knockdown of MAT2A alleviates CCl4- and TGF-β1-induced HSC activation, whereas in vivo overexpression of MAT2A facilitates hepatic fibrosis and abolishes therapeutic effect of NPLC0393. This study identifies TGF-β1/p65/MAT2A pathway that is involved in the regulation of intracellular SAM concentration and liver fibrogenesis, suggesting that this pathway is a potential therapeutic target for hepatic fibrosis. FUND: This work was supported by National Natural Science Foundation of China (No. 81500469, 81573873, 81774196 and 31800693), Zhejiang Provincial Natural Science Foundation of China (No. Y15H030004), the National Key Research and Development Program from the Ministry of Science and Technology of China (No. 2017YFC1700200) and the Key Program of National Natural Science Foundation of China (No. 8153000502).

22 December 2021 in Expert Review of Vaccines
Verified
Journal Article
Closed access
TTTao-Hsin Tung
Tao-Hsin Tung
XLXiao-Qing Lin
Xiao-Qing Lin
YCYan Chen
Yan Chen
MZMeixian ZHANG
Meixian ZHANG
JZJiansheng Zhu
Jiansheng Zhu
This population-based study aimed to determine willingness to receive a booster dose of vaccine against coronavirus disease (COVID-19) in Taizhou, China.An online questionnaire investigation addres...

1 July 2020 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
LHLu-Xiao Hong
Lu-Xiao Hong
ALAifen Lin
Aifen Lin
ZHZe-Bao He
Ze-Bao He
HZHai-Hong Zhao
Hai-Hong Zhao
JZJian-Gang Zhang
Jian-Gang Zhang
WYWei-Hua Yan
Wei-Hua Yan

10 June 2022 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
YCYan Chen
Yan Chen
MZMeixian ZHANG
Meixian ZHANG
XLXiao-Qing Lin
Xiao-Qing Lin
HWHongwei Wu
Hongwei Wu
TTTao-Hsin Tung
Tao-Hsin Tung
JZJiansheng Zhu
Jiansheng Zhu
Studies have identified teacher effects on students’ attitudes. This study explored the differences in and associations between teachers’ and students’ COVID-19 vaccine hesitancy, and the factors that affect it. A population-based self-administered online survey was conducted to evaluate the COVID-19 vaccine hesitancy of teachers and students in a college in Taizhou, China. A total of 835 valid questionnaires were obtained. All data were analyzed using IBM SPSS statistics 26.0 software. The proportions of COVID-19 vaccine hesitancy for teachers and students were 31.7%, and 23.8%, respectively. In the binary logistic regression analysis, teachers who perceived the safety of the COVID-19 vaccine as low (OR = 6.794 , 95%CI: 1.701–27.143), did not pay continuous attention to the vaccine news (OR = 3.498, 95%CI: 1.150–10.640), and suffered chronic diseases (OR = 2.659, 95%CI: 1.135–6.227) were more likely to hesitate to get vaccinated against COVID-19. The group of students who perceived the COVID-19 vaccine safety as being low (OR = 1.805, 95%CI: 1.094–2.979) were more hesitant to get the COVID-19 vaccine. While both teachers and students were hesitant about the COVID-19 vaccine, teachers were found to be more so. Perceptions regarding the safety of COVID-19 vaccines, attention to and awareness of vaccine news, and chronic medical conditions were the main factors that influenced the hesitation regarding COVID-19 vaccines. Therefore, students’ vaccine hesitancy may depend largely on the perceptions of the vaccine’s safety rather than teachers’ vaccine hesitancy.

6 December 2017 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
NZNi Zhou
Ni Zhou
KWKuifeng Wang
Kuifeng Wang
SFShanhua Fang
Shanhua Fang
XZXiaoyu Zhao
Xiaoyu Zhao
THTingting Huang
Tingting Huang
JZJiansheng Zhu
Jiansheng Zhu
Hepatitis B virus (HBV)-associated acute-on-chronic liver failure (HBV-ACLF), characterized by an acute deterioration of liver function in the patients with chronic hepatitis B (CHB), is lack of predicting biomarkers for prognosis. Plasma is an ideal sample for biomarker discovery due to inexpensive and minimally invasive sampling and good reproducibility. In this study, immuno-depletion of high-abundance plasma proteins followed by iTRAQ-based quantitative proteomic approach was employed to analyze plasma samples from 20 healthy control people, 20 CHB patients and 20 HBV-ACLF patients, respectively. As a result, a total of 427 proteins were identified from these samples, and 42 proteins were differentially expressed in HBV-ACLF patients as compared to both CHB patients and healthy controls. According to bioinformatics analysis results, 6 proteins related to immune response (MMR), inflammatory response (OPN, HPX), blood coagulation (ATIII) and lipid metabolism (APO-CII, GP73) were selected as biomarker candidates. Further ELISA analysis confirmed the significant up-regulation of GP73, MMR, OPN and down-regulation of ATIII, HPX, APO-CII in HBV-ACLF plasma samples (p < 0.01). Moreover, receiver operating characteristic (ROC) curve analysis revealed high diagnostic value of these candidates in assessing HBV-ACLF. In conclusion, present quantitative proteomic study identified 6 novel HBV-ACLF biomarker candidates and might provide fundamental information for development of HBV-ACLF biomarker.